• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [267 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Ventricular assist devices for heart failure]
2007 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Mechanical circulatory assistance - systematic review, expert panel (update)
2007 The Swedish Council on Health Technology Assessment (SBU) Cardiac Resynchronization Therapy (CRT) in Chronic Heart Failure ; early assessment briefs (Alert)
2007 NIHR Horizon Scanning Centre (NIHR HSC) Tolvaptan for heart failure (NYHA): horizon scanning technology briefing
2007 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model
2007 Adelaide Health Technology Assessment (AHTA) B-type natriuretic peptide assays in the diagnosis of heart failure. Part A: in the hospital emergency setting. Part B: in the non-hospital setting
2007 Quality Improvement Scotland (NHS QIS ) Cardiac resynchronisation therapy for the treatment of heart failure
2007 Medical Services Advisory Committee (MSAC) Brain natriuretic peptide assays in the diagnosis and monitoring of heart failure
2006 The Netherlands Organisation for Health Research and Development (ZonMw) [Adherence to guidelines in ambulatory patients with mild heart failure and associated organisational factors]
2006 Alberta Heritage Foundation for Medical Research (AHFMR) Prognostic value of B-type natriuretic peptide for congestive heart failure
2006 Blue Cross Blue Shield Association (BCBS) External counterpulsation for treatment of chronic stable angina pectoris and chronic heart failure
2006 Medical Advisory Secretariat (MAS) Enhanced external counterpulsation (EECP): an evidence-based analysis
2006 Medical Services Advisory Committee (MSAC) Cardiac resynchronisation therapy for severe heart failure
2006 University HealthSystem Consortium (UHC) Conivaptan
2006 HAYES, Inc. Extracorporeal membrane oxygenation for heart failure (children and adults)
2006 Agency for Healthcare Research and Quality (AHRQ) Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure
2006 Medical Services Advisory Committee (MSAC) B-type natriuretic peptide assays in the diagnosis of heart failure
2006 Adelaide Health Technology Assessment (AHTA) Nurse-led telephone program to monitor heart failure patients after hospital discharge
2006 Adelaide Health Technology Assessment (AHTA) Autologous bone marrow transplant for the treatment of patients who have experienced heart failure
2006 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Cardiac rehabilitation - a health technology assessment: evidence from the literature and the DANREHAB trial]
2006 The Swedish Council on Health Technology Assessment (SBU) Role of natriuretic peptides in diagnosing heart failure - early assessment briefs (Alert)
2006 NIHR Horizon Scanning Centre (NIHR HSC) Ultrafiltration for acute decompensated heart failure: horizon scanning technology briefing
2006 National Institute for Health and Care Excellence (NICE) Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery. NICE interventional procedures guidance 177
2005 Quality Improvement Scotland (NHS QIS ) The use of B-type natriuretic peptides in the investigation of patients with suspected heart failure; Understanding our Advice: The use of B-type natriuretic peptides in the investigation of patients with suspected heart failure
2005 Alberta Heritage Foundation for Medical Research (AHFMR) Cost estimation of point of care b-type natriuretic peptide for the diagnosis of heart failure in the emergency department:application to Alberta
2005 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) External counterpulsation - preliminary report
2005 Institute for Clinical Systems Improvement (ICSI) B-type natriuretic peptide (BNP) for the diagnosis and management of congestive heart failure
2005 Institute for Clinical Effectiveness and Health Policy (IECS) Levosimendan for the treatment of decompensated heart failure
2005 Quality Improvement Scotland (NHS QIS ) The use of cardiac resynchronization therapy (CRT) for heart failure
2005 Alberta Heritage Foundation for Medical Research (AHFMR) Efficacy of B-type natriuretic peptide-guided treatment for congestive heart failure
2005 Belgian Health Care Knowledge Centre (KCE) Natriuretic peptides in the diagnostic work-up of patients with suspected heart failure
2005 HAYES, Inc. Cardiac resynchronization therapy for heart failure
2005 Medical Advisory Secretariat (MAS) Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis
2005 West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost effectiveness of biventricular pacing for patients with severe heart failure: addendum report ; January 2005 [updated January 2006]
2005 HAYES, Inc. Candesartan cilexetil for heart failure
2005 Medical Services Advisory Committee (MSAC) Treatment of heart failure by permanent tri-chamber synchronisation (#1042)
2004 Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of biventricular pacemakers at the McGill University Health Centre
2004 Blue Cross Blue Shield Association (BCBS) Cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure
2004 Alberta Heritage Foundation for Medical Research (AHFMR) B-type natriuretic peptide for diagnosing congestive heart failure
2004 Medical Advisory Secretariat (MAS) Biventricular pacemaker
2004 Medical Advisory Secretariat (MAS) Left ventricular assist devices: an evidence-based analysis
2004 Agency for Healthcare Research and Quality (AHRQ) Cardiac resynchronization therapy for congestive heart failure
2004 NIHR Horizon Scanning Centre (NIHR HSC) Levosimendan for acute heart failure - horizon scanning review
2004 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Mechanical heart assist devices - systematic review, expert panel
2004 Institute for Clinical Effectiveness and Health Policy (IECS) Implantable heart defibrillators
2004 ECRI B-type natriuretic peptide for diagnosing heart failure
2004 Medical Services Advisory Committee (MSAC) Implantable cardiac defibrillators for chronic heart failure
2004 Adelaide Health Technology Assessment (AHTA) Left ventricular assist devices for destination therapy
2004 Adelaide Health Technology Assessment (AHTA) Elecsys (R) ProBNP Immunoassay for the diagnosis of congestive heart failure
2004 Adelaide Health Technology Assessment (AHTA) Elecsys (R) proBNP immunoassay for the diagnosis of congestive heart failure. Horizon scanning prioritising summary.
2004 Adelaide Health Technology Assessment (AHTA) Medtronic (R) InSync (R) III biventricular pacing system: cardiac resynchronisation therapy in patients with congestive heart failure
2004 National Institute for Health and Care Excellence (NICE) Partial left ventriculectomy (the Batista procedure). NICE interventional procedures guidance 41
2004 National Institute for Health and Care Excellence (NICE) Extracorporeal membrane oxygenation (ECMO) in postneonatal children. NICE interventional procedures guidance 38
2003 Wessex Institute for Health Research and Development (WIHRD) Cardiac resynchronisation for heart failure
2003 The Swedish Council on Health Technology Assessment (SBU) Pacemaker resynchronization of ventricular rhythm (CRT) in chronic heart failure - early assessment briefs (Alert)
2003 Medical Advisory Secretariat (MAS) Enhanced external counterpulsation (EECP)
2003 Institute for Clinical Effectiveness and Health Policy (IECS) Cardiac resynchronization therapy: biventricular or three chamber pacemaker
2003 Adelaide Health Technology Assessment (AHTA) Thoratec heartmate (R) left ventricular assist device for patients with heart failure who are ineligible for heart transplantation
2002 Institute for Clinical Systems Improvement (ICSI) Left ventricular assist devices as permanent implants
2002 Blue Cross Blue Shield Association (BCBS) Left-ventricular assist devices as destination therapy for end-stage heart failure
2002 NIHR Horizon Scanning Centre (NIHR HSC) Nesiritide for acute heart failure - horizon scanning review
2002 Agency for Healthcare Research and Quality (AHRQ) Thoracic electrical bioimpedance
2002 HAYES, Inc. Cardiac resynchronization therapy for heart failure
2002 ECRI Biventricular pacing systems (cardiac resynchronization therapy) for heart failure
2001 VA Technology Assessment Program (VATAP) Physiologic telemonitoring in CHF
2001 HAYES, Inc. Brain natriuretic peptide test for diagnosis of congestive heart failure
1999 Wessex Institute for Health Research and Development (WIHRD) Left ventricular assist devices (LVADs) for end stage heart failure